ThomasF.ScottMD

Neurology • Pittsburgh, PA

Neuroimmunology/Multiple Sclerosis

Physician

Join to view full profile

Dr. Scott is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Scott's full profile

Already have an account?

Office
490 E North Ave
Ste 500
Pittsburgh, PA 15212
Phone+1 412-359-8850

Fax+1 412-359-8878
Is this information wrong?

Education & Training

Medical University of South CarolinaChief Residency, Neurology, 1986 - 1989
Riverside Regional Medical CenterInternship, Transitional Year, 1985 - 1986
West Virginia University School of MedicineClass of 1985

Certifications & Licensure

PA State Medical License 1989 - 2024
SC State Medical License 1986 - 1989
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Top Docs
Best Clinical Paper 2013 Journal Multiple Sclerosis JMS, 2014
Who's who in medicine, Frequent reviewer award Neurology, Teaching awards Drexel University Sch Med and Temple Univ. Sch> Med, Full professor since 2003, Multiple publications and editorial positions in top journals

Clinical Trials

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis Start of enrollment: 2001 Feb 01
Completed
Phase 4
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial Start of enrollment: 2018 May 02
Recruiting
Not Applicable

Publications & Presentations

PubMed

2 citations
Early treatment responses to peginterferon beta-1a are associated with longer-term clinical outcomes in patients with relapsing-remitting multiple sclerosis: Subgroup ...
Scott D. Newsome, Thomas F. Scott, Douglas L. Arnold, Arman Altincatal, Maria L. Naylor> ;Multiple Sclerosis and Related Disorders. 2021 Nov 3
4 citations
Neurosarcoidosis mimicry of MS: Clues from cases with CNS tissue diagnosis.
Thomas F. Scott> ;Journal of the Neurological Sciences. 2021 Aug 23
1 citations
Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc A...
Samuel F. Hunter, Rany A Aburashed, Raed Alroughani, Andrew T. Chan, Dominique Dive, Sara Eichau, Daniel Kantor, Ho Jin Kim, Jan Lycke, Richard A L Macdonell, Carlo Po...> ;Neurology and Therapy. 2021 Jun 24
6 citations
Self-Reported Barriers to Exercise and Factors Impacting Participation in Exercise in Patients with Parkinson's Disease
Prarthana Prakash, Thomas F. Scott, Susan Baser, Timothy Leichliter, Carol J. Schramke> ;Movement Disorders Clinical Practice. 2021 May 1
Word cloud for hospitalization admission diagnoses in patients with multiple sclerosis.
Rebecca L. Vislay-Wade, Thomas F. Scott> ;Multiple Sclerosis and Related Disorders. 2021 Feb 1
Real world prognosis in MS: does early versus late diagnosis matter?
Jikku Zachariah, Timothy Quezada, Troy Desai, Rebecca E. Schorr, Thomas F. Scott> ;Neurological Research. 2021 Jan 12
Matching comparisons of therapeutic efficacy suggest better clinical outcomes for patients treated with peginterferon beta-1a than with glatiramer acetate:
Thomas F. Scott, Ray Su, Kuangnan Xiong, Arman Altincatal, Carmen Castrillo-Viguera, Maria L. Naylor> ;Therapeutic Advances in Neurological Disorders. 2021 Jan 12
Large hemispheric lesions in autoimmune encephalitis associated with anti-GAD 65 antibodies.
Bahareh Sianati, Sandeep Rana, Murat Sari, Jody Leonardo, Thomas F. Scott> ;Multiple Sclerosis and Related Disorders. 2020 Jun 25
2 citations
The impact of multiple sclerosis relapses on worsening over the long term; insights in the treatment era.
Thomas F. Scott, Nicholas Bertha> ;Journal of the Neurological Sciences. 2020 Jun 15
5 citations
Outcomes in a Modern Cohort of Treated Patients with Multiple Sclerosis from Diagnosis Up to 15 Years.
Thomas F. Scott, Troy Desai, Chris Hackett, Edward Gettings, Teresa Hentosz, Wisam Elmalik, Carol J. Schramke> ;International Journal of MS Care. 2020 May 1
Is baseline routine renal ultrasound indicated for all MS patients
Igor B. Títoff, Victoria Titoff, Thomas F Scott> ;Postgraduate Medical Journal. 2020 Apr 1
2 citations
A case of paroxysmal dystonia associated with LGI-1 antibody encephalitis.
Rahul Rahangdale, Thomas F. Scott, Timothy Leichliter, Susan Baser, James Valeriano> ;Clinical Neurology and Neurosurgery. 2019 Sep 3
9 citations
Multiple sclerosis relapses contribute to long-term disability.
Thomas F. Scott, Daniel Diehl, Wisam Elmalik, Edward Gettings, Chris Hackett, Carol J. Schramke> ;Acta Neurologica Scandinavica. 2019 Jul 17
3 citations
Glioneuronal Growth Infiltrating Lumbosacral Nerve Roots Following Intrathecal Stem Cell Injections Highlighting Perils of Stem Cell Tourism
Rahul Rahangdale, Sandeep Rana, Prarthana Prakash, Mohammad Ali, Mary Flaherty, Andrea S. Synowiec, Susan Baser, Thomas F. Scott> ;Movement Disorders Clinical Practice. 2019 Mar 12
12 citations
Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN.
Scott D. Newsome, Thomas F. Scott, Douglas L. Arnold, Gereon Nelles, Serena Hung, Yue Cui, Shulian Shang, Maria L. Naylor, Marcelo Kremenchutzky> ;Therapeutic Advances in Neurological Disorders. 2018 Aug 28
8 citations
Understanding the impact of relapses in the overall course of MS; refinement of the 2 stage natural history model.
Thomas F. Scott> ;Journal of Neuroimmunology. 2017 Apr 15
Transient IgG deficiency with lesions in brain and spinal cord: a mimicker of common variable immunodeficiency syndrome.
Konark Malhotra, Ramnath Santosh Ramanathan, Thomas F. Scott> ;Acta Neurologica Belgica. 2017 Sep 1
A man in his 40s with altered mental status, ataxia and unilateral weakness.
Konark Malhotra, Monica Khunger, Cunfeng Pu, Thomas F. Scott> ;Neuropathology. 2017 Jun 1
10 citations
Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis:
Thomas F. Scott, Bernd C Kieseier, Scott D. Newsome, Douglas L. Arnold, Xiaojun You, Serena Hung, Bjoern Sperling> ;Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2016 Nov 1
11 citations
Treatment of Neuropathic Pain and Functional Limitations Associated With Multiple Sclerosis Using an MRI-Compatible Spinal Cord Stimulator: A Case Report With Two Year...
David A. Provenzano, Joseph R. Williams, Gaye Jarzabek, Leonard DeRiggi, Thomas F. Scott> ;Neuromodulation. 2016 Mar 28
7 citations
Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes
Thomas F. Scott, Edward Gettings, Chris Hackett, Carol J. Schramke> ;Multiple Sclerosis and Related Disorders. 2016 Jan 1
1 citations
Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES.
Thomas F Scott> ;Multiple Sclerosis. 2015 Oct 1
77 citations
Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.
Edward Gettings, Chris Hackett, Thomas F. Scott> ;Multiple Sclerosis. 2015 Apr 1
9 citations
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Random...
Thomas F. Scott, Ping Wang, Xiaojun You, Monica Mann, Bjorn Sperling> ;Neuroepidemiology. 2015 Jan 1
11 citations
Relapsing multiple sclerosis patients treated with disease modifying therapy exhibit highly variable disease progression: A predictive model
Thomas F. Scott, Chris Hackett, Matthew R. Quigley, Carol J. Schramke> ;Clinical Neurology and Neurosurgery. 2014 Dec 1
Join now to see all

Journal Articles

Books/Book Chapters

Professional Memberships

American Academy of Neurology - AAN
Member
American Neurological Assoc.
elected member

Hospital Affiliations

Allegheny General HospitalPittsburgh, Pennsylvania
West Penn HospitalPittsburgh, Pennsylvania
Heritage Valley SewickleySewickley, Pennsylvania